Eli Lilly | LLY - Ebit



金融业
股票价格
USD 1,410.99
资产
USD 148.07B
现金及等价物
USD 4.89B
销售成本
USD 3.93B
流动资产
USD 65.26B
流动负债
USD 47B
债务
USD 54.91B
股息收益率
0.58
EBIT
USD 13.09B
EBITDA
USD 9.46B
员工
47K
EPS每股收益
USD 7.48
股本和储备
USD 40.27B
销售毛利
USD 20.59B
债务利息支出
USD 316M
利息收入
USD 65M
贷款资金
USD 46.99B
市值
USD 1329.82B
净收入
USD 7.1B
营业费用
USD 10.52B
营业利润
USD 12.46B
普通股股本
USD 943.5M
PE价格收益
64.5
税前利润
USD 8.79B
销售收入
USD 24.4B
销售和管理费用
USD 3.13B
股票
USD 18.19B
贸易债权人
USD 5.79B
应收帐款人
USD 23.48B


Ebit 更改 日
AbbVie USD 6.88B 156M 2026-09
Abbott USD 1.36B 775M 2026-09
ALKERMES USD -65.93M 17.65M 2026-06
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 13.52B 10.47B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merck USD 7.33B 6.49B 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Novo Nordisk DKK 33.76B 25.86B 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Sanofi EUR 1.12B 1.06B 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Zoetis USD 1.12B 279M 2026-06